Scinai CEO Co-Leads Biopharma Manufacturing Roundtable at HealthIL Week 2026
I'm PortAI, I can summarize articles.
Scinai Immunotherapeutics Ltd. announced that its CEO, Amir Reichman, will co-lead a biopharma manufacturing roundtable during HealthIL Week 2026 at Expo Tel Aviv. The session, organized by the Manufacturers Association of Israel, will gather various stakeholders to discuss Israel’s biopharma ecosystem, focusing on early-stage development, clinical manufacturing, and the role of CDMOs. The aim is to enhance Israel’s capabilities in supporting biopharma companies from early clinical stages to commercial manufacturing.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments